Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medical Developments International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Medical
Z Score
Sale Purchase Of Stock
Change In Cash
Free Cash Flow
Begin Period Cash Flow
Other Cashflows From Financing Activities
Depreciation
Other Non Cash Items
Capital Expenditures
Total Cash From Operating Activities
Net Income
Total Cash From Financing Activities
End Period Cash Flow
Dividends Paid
Change To Inventory
Other Cashflows From Investing Activities
Change To Account Receivables
Stock Based Compensation
Change In Working Capital
Net Borrowings
Total Cashflows From Investing Activities
Change To Operating Activities
Change To Netincome
Change To Liabilities
Investments
Issuance Of Capital Stock
Total Assets
Short Long Term Debt Total
Total Current Liabilities
Total Stockholder Equity
Property Plant And Equipment Net
Net Debt
Accounts Payable
Cash
Non Current Assets Total
Cash And Short Term Investments
Net Receivables
Common Stock Total Equity
Common Stock Shares Outstanding
Liabilities And Stockholders Equity
Non Current Liabilities Total
Inventory
Other Current Assets
Total Liab
Property Plant And Equipment Gross
Total Current Assets
Short Term Debt
Intangible Assets
Common Stock
Other Current Liab
Other Liab
Current Deferred Revenue
Retained Earnings
Other Assets
Long Term Debt
Good Will
Other Stockholder Equity
Accumulated Other Comprehensive Income
Property Plant Equipment
Non Currrent Assets Other
Net Tangible Assets
Deferred Long Term Liab
Short Long Term Debt
Long Term Debt Total
Non Current Liabilities Other
Net Invested Capital
Cash And Equivalents
Net Working Capital
Capital Stock
Capital Lease Obligations
Depreciation And Amortization
Interest Expense
Total Revenue
Gross Profit
Other Operating Expenses
Operating Income
Ebit
Ebitda
Total Operating Expenses
Income Before Tax
Total Other Income Expense Net
Income Tax Expense
Selling General Administrative
Selling And Marketing Expenses
Cost Of Revenue
Net Income Applicable To Common Shares
Research Development
Net Income From Continuing Ops
Tax Provision
Net Interest Income
Interest Income
Reconciled Depreciation
Probability Of Bankruptcy
At this time, Medical Developments' Net Invested Capital is comparatively stable compared to the past year. Net Working Capital is likely to gain to about 22 M in 2025, whereas Issuance Of Capital Stock is likely to drop slightly above 20.4 M in 2025. At this time, Medical Developments' Net Interest Income is comparatively stable compared to the past year.
Medical Developments International Company Z Score Analysis
Medical Developments' Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
Based on the company's disclosures, Medical Developments International has a Z Score of 0.0. This indicator is about the same for the Pharmaceuticals average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all Australia stocks average (which is currently at 0.0).
Did you try this?
Run Latest Portfolios Now
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
The Macroaxis Fundamental Analysis modules help investors analyze Medical Developments International's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medical Developments using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medical Developments International based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
When running Medical Developments' price analysis, check to measure Medical Developments' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medical Developments is operating at the current time. Most of Medical Developments' value examination focuses on studying past and present price action to predict the probability of Medical Developments' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medical Developments' price. Additionally, you may evaluate how the addition of Medical Developments to your portfolios can decrease your overall portfolio volatility.